Understanding the actions of aflibercept and other anti-VEGF agents in a retinopathy model would help to further elucidate whether modulation of ANG2 and other additional factors directly or indirectly impacts the development or progression of retinopathy. This evidence concerns the gene ANGPT2 and retinal disorder.